Business Context and Reporting Period
This Form 6-K filing by Grifols, S.A. is dated June 11, 2025, and covers the month of June 2025. The report details the conclusion of a public delisting purchase offer launched by Grifols' subsidiary, Grifols Biotest Holdings GmbH, to acquire all outstanding shares of Biotest Aktiengesellschaft (Biotest).
Key Financial Metrics and Transaction Details
- Offer Price: €43.00 per ordinary share and €30.00 per non-voting preferred share.
- Shares Accepted: 416,922 ordinary shares and 3,002,804 non-voting preferred shares.
- Total Consideration: €108,011,766 to be paid for the accepted shares.
- Post-Transaction Ownership: Grifols will hold 99.25% of Biotest's voting ordinary shares and 61.40% of its non-voting preferred shares.
- Settlement Date: Expected on June 16, 2025.
Material Changes and Status
The acceptance period for the Delisting Offer concluded on June 6, 2025. Consequently, Biotest has received formal approval from the Frankfurt Stock Exchange to revoke the admission of its shares to trading. The delisting became effective as of June 6, 2025, and Biotest shares are no longer traded on the exchange.
Outlook and Management Commentary
Management confirms that the settlement of the Delisting Offer and payment of the offer price will occur no later than the fourth business day following this communication. The filing serves as a continuation of privileged information notes previously filed on March 31, 2025, and May 6, 2025. No specific financial guidance, risk factors, or unusual items regarding Grifols' broader operations were disclosed in this specific filing.
Key Facts for Investor Verification
- Verify the final settlement of the €108,011,766 payment on or before June 16, 2025.
- Confirm the updated ownership structure of Biotest, specifically the 99.25% stake in voting shares.
- Monitor the status of the remaining 38.60% of non-voting preferred shares not acquired in this offer.
- Check for subsequent filings regarding the integration of Biotest following the delisting.